Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINDESINE for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 279 adverse event reports in the FDA FAERS database where VINDESINE was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for VINDESINE

Side Effect Reports % Deaths Hosp.
Myelosuppression 429 22.1% 5 263
Off label use 148 7.6% 21 60
Bone marrow failure 141 7.3% 20 79
Pyrexia 138 7.1% 6 94
Anaemia 137 7.0% 23 41
Leukopenia 127 6.5% 14 31
White blood cell count decreased 124 6.4% 3 54
Febrile neutropenia 115 5.9% 14 65
Pneumonia 110 5.7% 30 28
Thrombocytopenia 93 4.8% 22 23
Neutropenia 89 4.6% 16 28
Neutrophil count decreased 87 4.5% 5 28
Drug ineffective 85 4.4% 23 29
Infection 69 3.6% 30 25
Disease progression 67 3.4% 22 16

Other Indications for VINDESINE

Acute lymphocytic leukaemia (272) Non-hodgkin's lymphoma (131) Chemotherapy (118) Lymphoma (104) B-cell lymphoma (93) Hodgkin's disease (74) Neuroblastoma (65) Adult t-cell lymphoma/leukaemia (61) Burkitt's lymphoma (58) Product used for unknown indication (44)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

VINDESINE Full Profile All Diffuse large b-cell lymphoma Drugs VINDESINE Demographics VINDESINE Timeline